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Summary - In the karyotypes of the bat species Molossus ater and M molossus,
spontaneous and bromodeoxyuridine (BrdU)- or aphidicolin (APC)-sensitive fragile sites
were located. Four chromosome regions harbored APC-sensitive fragile sites: lq9 and 8q4
in both M ater and M molossus, 3q3 in M ater, and lp7 in M molossus. The fragile sites in
lq9 and 8q4 were also observed without induction in M molossus. BrdU-sensitive fragile
sites were not detected. Despite observations in several other species, the fragile sites
detected in Molossus are not coincident with the breakpoints involved in the chromosome
rearrangements occurring in the evolution of 7 species of the Molossidae family.
fragile site / chromosome / bat / bromodeoxyuridine induction / aphidicolin
induction
Résumé - Identification de sites chromosomiques fragiles communs à 2 espèces
de chauve-souris. L’analyse de la fragilité chromosomique spontanée ou induite par
bromodéoxyuridine (BrdU) et aphidicholine (APC), réalisée sur le caryotype de 2 espèces
de chauve-souris, Molossus ater et M molossus, a permis d’identifier 4 sites fragiles induits
par APC: 1 q9 et 8q4 chez M ater et M molossus, 3q3 chez M ater et 1 p7 chez M molossus.
Les sites fragiles en 1 q9 et 8q4 ont aussi été observés chez M molossus sans induction.
Les sites fragiles repérés dans ces espèces ne coincident pas avec les points de cassure
impliqués dans les réarrangements chromosomiques qui ont eu lieu au cours de l’évolution
de 7 espèces de la famille des Molossidae.
site fragile / chromosome / chauve-souris / induction par bromodéoxyuridine /
induction par aphidicholine
INTRODUCTION
Fragile sites are specific points on chromosomes which are expressed as non-
randomly distributed gaps and breaks when chromosomes are exposed to specific
agents or culture conditions (Berger et al, 1985). The induction of fragile site
expression is generally related to imbalance of deoxyribonucleotide pools during
G1 and S phases following thymidylate stress (Yan et al, 1988) or treatment
with the thymidine analogue bromodeoxyuridine (BrdU) (Sutherland et al, 1985).
Expression of fragile sites can also be induced at high frequencies by inhibitors
of DNA semiconservative and repair synthesis, including aphidicolin (Glover et al,
1984), arabinofuranosyl cytosine, and arabinofuranosyl adenosine (Leonard et al,
1988).
Although the biological significance of fragile sites remains unclear, they have
attracted attention since the rare fragile site in Xq27.3 and a type of X-linked mental
retardation in humans were associated (Sutherland and Hecht, 1985). Furthermore,
several findings have correlated fragile sites with chromosomal rearrangements in
cancer (Le Beau, 1986; De Braekeleer, 1987; Mir6 et al, 1987), infertility in humans
(Schlegelberger et al, 1989), breakpoints involved in chromosomal evolution of
primates (Mir6 et al, 1987), and preservation of syntenic groups in mammals (Djalali
et al, 1987; Threadgill and Womack, 1989).
More than 100 fragile sites have been identified in human chromosomes, all
classified by their band location, gene symbol, population frequencies, and mode
of induction (Mir6 et al, 1987; Hecht et al, 1990). BrdU-sensitive fragile sites have
also been described in Chinese hamsters (Hsu and Sommers, 1961; Lin et al, 1984),
cactus mice (Schneider et al, 1980), cattle (Di Berardino et al, 1983), and reindeer
(Gripenberg et al, 1991). BrdU- and/or folate-sensitive fragile sites were recently
reported in the horse karyotype (Ronne, 1992). Aphidicolin (APC)-sensitive fragile
sites have been detected in the chromosomes of mice (Djalali et al, 1987; Elder
and Robinson, 1989; McAllister and Greenbaum, 1991), rats (Robinson and Elder,
1987), dogs (Wurster-Hill et al, 1988; Stone et al, 1991a, 1991b), pigs (Riggs and
Chrisman, 1991), and rabbits (Poulsen and Ronne, 1991). Folate-sensitive fragile
sites were detected in the Persian vole (Djalali et al, 1985), the mouse (Sanz et al,
1986), cattle (Uchida et al, 1986), and in the Indian mole rat (Tewari et al, 1987).
To determine the potential phylogenetic implications of chromosomal fragility
in the evolution of bats, common BrdU- and APC-sensitive fragile sites in the
karyotype of 2 species of the family Molossidae (Chiroptera, Mammalia) were
examined.
MATERIALS AND METHODS
Primary cultures of fibroblasts were derived from explants of ears from a total of
9 animals of the species Molossus ater and 8 from Molossus molossus. The cultures
were established and maintained in Eagles’ minimum essential medium (MEM)
supplemented with 20% fetal calf serum, L-glutamine, penicillin and streptomycin.
BrdU (20 gM) and APC (0.02 gM) were added to cultures 26 h before harvest. In
order to avoid the photolysis of DNA containing BrdU, the culture flasks were kept
in the dark and covered with aluminium foil after BrdU was added. Each experiment
was performed with concurrent control cultures. Colchicine (4 x 10-4M) was added
to the cultures 30 min before harvest. Cells were exposed to 0.8% sodium citrate for
30 min, fixed in methanol/acetic acid 3:1, dropped onto wet slides, and air-dried.
Slides were homogeneously stained with 2% Giemsa and around 100 metaphases
from coded slides of treated and untreated cultures of each animal were scored for
breaks, gaps, and rearrangements. After identification of the lesion, the slides were
destained and GTG banding (G-band after trypsin and giemsa treatment) was used
to identify the exact localization of the aberrations.
To determine the presence of a fragile site, 2 criteria were considered: (i) the
occurrence of at least 2% lesions at a given chromosome region in cells submitted
to a certain culture condition in at least 2 animals of the same species; and (ii) the
homozygous expression of a lesion. A chi-squared analysis of the distribution of
anomalies was performed to determined whether their frequencies were equally
distributed in treatments and controls.
RESULTS
The diploid number of chromosomes in M ater and M molossus is 2n = 48 and their
karyotypes have similar morphology and G-band pattern (fig 1). The frequencies
of spontaneous, BrdU- and APC-induced lesions in bat chromosomes are given in
table I. These lesions manifested themselves as either nonstaining gaps, chromatid
or chromosome breaks, or deletions.
The number of aberrations in BrdU-treated and untreated (control) cultures of
M ater and M molossus was low, but BrdU-treated cells were significantly more
damaged than controls (x2 = 8.9; 1 df; P < 0.05). Only 3.6% of the cells in the
BrdU-treated cultures and 0.6% of cells in the control cultures showed chromosome
lesions in M ater, with a total of 20 and 3 events, respectively. In M molossus 3.8% of
the cells in the control culture and 4.8% of BrdU-treated cells showed chromosome
lesions, with a total of 18 and 19 events, respectively. The location of these gaps
and breaks was variable but they occurred in the euchromatic chromosome arms.
Chromatid gap was the most frequent event.
Four chromosome bands exhibited lesions in at least 2% of the cells in the BrdU-
treated cultures: lq5 and lq9 in M ater; 1q13 and 8q4 in M molossus. M molossus
also exhibited lesions in lp7 in the control cultures. Nevertheless, none of these
bands were considered to harbor fragile sites since the aberrations were not observed
in the homozygous conditions or in more than one animal of the same species.
The APC treatment was more effective in the induction of chromosomal aberra-
tions than BrdU: 9.2% of the cells presented a total of 50 anomalies in M ater; 11.5%
of the cells exhibited a total of 75 aberrations in M molossus (table I). More than
one lesion or the homozygous expression of a given aberration occurred in a number
of cells. In these tests, the most frequent type of aberration was the chromosome
gap. The chi-squared analysis detected significantly more damaged chromosomes in
the APC-treated than in the control cultures (x2 = 20.0; 1 df; P < 0.001).
Fourteen regions in the euchromatic arms in which such lesions occurred were
identified in at least 2% of the cells: lp7, lq5, lq9, 1q13, 3q3, 4q3-4, 5q8, 7q3-4,
8q4, 8q5-6, lOq3-4, 20q2 and Xq4-6 in the APC-treated cultures and 1q13-15 in the
control cultures (fig 2A). However, only 4 of these 14 regions fulfilled the criteria
to be qualified as harboring fragile sites (fig 2B): lq9 and 8q4 in both M ater and
M molossus, lp7 in M Molossus, and 3q3 in M ater. The fragile sites in lq9 and
8q4 were also observed without induction in M molossus. The highest expression
rate (8%) was achieved by 8q4. Furthermore, an interindividual variation in the
frequencies of expression of the fragile sites was observed in all of the 4 bands, as
well as an interspecific variation observed in lq9 and 8q4.
It is important to emphasize that the 5 bands referred to above as presenting
lesions in the test with BrdU (lp7, lq5, lq9, 1q13 and 8q4) are included in the
14 identified in APC treatment and 3 (1p7, lq9, and 8q4) are included in the 4 that
harbored fragile sites.
DISCUSSION
The mechanisms of expression of the BrdU-sensitive fragile site are not totally
understood. The chronology of the events after exposure to this chemical indicates
that it acts during the late S-phase and affects late replicating regions (Sutherland
et al, 1984, 1985). An increased frequency of gaps and breaks in the chromosomes
of M ater and M molossus was observed when the thymidine analogue BrdU was
incorporated. However, the frequencies and conditions in which these alterations
were expressed did not fit the criteria for qualification of the affected region as
harboring fragile sites. These findings may be related to the period of exposure to
BrdU (26 h). Although exposure to BrdU for 18-26 h has been used for experiments
with human lymphocytes and several mammalian fibroblasts (Schneider et al, 1980;
Lin et al, 1984; Fundia and Larripa, 1989), the highest expression of common BrdU-
sensitive fragile sites in human lymphocytes was achieved after 4-12 h of treatment
(Sutherland et al, 1984, 1985). Furthermore, fragile sites have been identified in
both lymphocyte and fibroblast cultures, but the cells in the latter appear refractory
to their expression (Robinson and Elder, 1987). Hence, the lower frequency in the
expression of the fragile sites in bat fibroblasts may be due to the specific refractivity
of this cell type as well as to a susceptibility of lymphocytes.
The chromosome aberrations observed in BrdU-treated cells in the present study
consisted mainly of chromatid gaps, which is similar to the findings of Lin et al
(1984) in the hamster genome. Reviewing the genetic toxicology of BrdU, Morris
(1991) also confirmed that the aberrations induced by this chemical were primarily
of the chromatid type and included gaps, breaks and interchanges.
APC, a diterpenoid mycotoxin that inhibits alpha DNA polymerase associated
with DNA replication, induces gaps and breaks at common fragile sites in human
chromosomes (Glover et al, 1984), either as chromosome or chromatid aberrations
(Murano et al, 1989). The most frequent type of aberration exhibited by APC-
treated cells in this study was the chromosome gap. The results may reflect the
number of cycles a cell had completed after the introduction of APC into cultures,
and/or even the efficiency of the repair mechanisms.
It is interesting to note that the fragility observed in the Xq4-6 was displayed by
only 1 animal of the species M ater, and so this region was not qualified as harboring
a fragile site in this work. Corresponding X-fragility has been observed in several
distantly related mammalian species including humans, horses, rats, rabbits, pigs,
dogs, and cattle (Ronne et al, 1993). The putative Xq4-6 fragility observed in this
study may then correspond to the Xq22 fragility observed in humans, horses, and
rats (Ronne et al, 1993).
Since the species present complete homology in their karyotypes, the interspe-
cific variation was surprising. Conservation of 5-azacytidine-sensitive fragile sites
was described in primates (Schmid et al, 1985), as well as fragility in bands shared
by horses and humans (Ronne, 1992). Beyond the interspecific and interindividual
variations observed in the number of regions harboring fragile sites, individual vari-
ation in the frequency of cells expressing the fragile sites was also observed among
positive specimens, as previously reported, for instance, in rabbits (Poulsen and
Ronne, 1991) and humans (Craig-Holmes et al, 1987). Variation in the molecular
nature of the fragile sites could explain variation in expressivity, as exemplified by
the human fragile site in Xq27.3. A highly polymorphic CGG repeat was discovered
within the gene FMR-1 mapped in this region and a somatic mosaicism was well
documented, indicating mitotic instability of alleles (Fu et al, 1991). Large expan-
sions of the repeated region (250-4 000 repeats) are probably more easily detected
by cytogenetic analysis than small expansions (52-200 repeats).
Despite the observed association between the fragile sites and the breakpoints
involved in chromosomal rearrangements in several animal species (Djalali et al,
1985; Mir6 et al, 1987; Riggs and Chrisman, 1991), our results did not show any
coincidence between the detected bands harboring fragile sites in the species of
Molossus and the breakpoints involved in chromosomal rearrangements occurring
in the evolution of 7 species of the family Molossidae (Morielle-Versute, 1992).
However a more detailed study is necessary to verify the complete relationship
between these 2 phenomena in bats.
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